Position in PYXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$242,196
+$217,658 QoQ
Shares Held
80,464
+378.8% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 76 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PYXS ranks #278 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PYXS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,196 | 80,464 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,538 | 16,807 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $676,028 | 587,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,367,346 | 615,922 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $24,275 | 22,069 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,516 | 40,323 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $83,841 | 53,745 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $163,986 | 44,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $148,228 | 44,782 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $126,577 | 29,713 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $35,719 | 19,844 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $200,698 | 100,854 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $334,548 | 130,683 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $94,202 | 23,492 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $85,217 | 63,595 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $39,567 | 20,085 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,442 | 15,732 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $81,922 | 20,278 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $313,916 | 28,616 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||